Detection of inflow obstruction in left ventricular assist devices by accelerometer: An in vitro study
Open Access
- 8 November 2022
- journal article
- research article
- Published by IOP Publishing in Medical Engineering & Physics
- Vol. 110 (1) , 103917
Abstract
Inflow obstruction in left ventricular assist devices (LVAD) may lead to embolic stroke and pump malfunction. We investigated if an accelerometer detected graded LVAD inflow obstructions. Detection performances were compared to the current continuous surveillance routine based on the pump power consumption (PLVAD). In ten mock circuit experiments, four different-sized pendulating balloons obstructed HVAD™ inflow conduits cross-section areas by 14%-75%. Nonharmonic amplitudes (NHA) of continuous signals from a triaxial accelerometer attached to the LVAD were compared against single-point PLVAD values, using load and speed alterations as control interventions. We analyzed the NHA band power with a pairwise nonparametric statistical test. The detection performances were analyzed by receiver operating characteristics with areas under the curves (AUC). The NHA remained unaffected during load alterations. In contrast, NHA increased significantly from the 27% obstruction level (AUC≥0.82), an effect amplified by increased pump speed. PLVAD did not change significantly below the maximal 75% obstruction level (AUC≤0.36). In conclusion, NHA detected the inflow obstructions much better than PLVAD. The technique may provide a future monitoring modality of any pendulating obstructive inflow pathology.Keywords
Funding Information
- South-Eastern Norway Regional Health Authority
This publication has 2 references indexed in Scilit:
- Improved Detection Of Thromboembolic Complications In Left Ventricular Assist Device By Novel Accelerometer-Based AnalysisASAIO Journal, 2022
- Primary results of long‐term outcomes in the MOMENTUM 3 pivotal trial and continued access protocol study phase: a study of 2200 HeartMate 3 left ventricular assist device implantsEuropean Journal of Heart Failure, 2021